This paper presents an open label 1:1 randomized controlled trial protocol comparing intervention and control groups to determine the effect of mHealth-based exercise on Insulin Sensitivity for patients with HCC and insulin resistance (mISH) after anticancer therapy. This evidence concerns the gene INS and hepatocellular carcinoma.